Industry Insights 2026

Pharmacovigilance & Regulatory Excellence

Expert analysis on NDCT Rules 2026, GAMP 5 compliance, and the evolving landscape of drug safety in India.

Navigating the 2026 NDCT Rule Amendments: The New
February 18, 2026

Navigating the 2026 NDCT Rule Amendments: The New "Trust-Based" Currency

The landscape of Indian clinical research and drug manufacturing changed fundamentally on January 20, 2026. With the notification of the New Drugs and Clinical ...

Read Analysis →
Pharmacovigilance India 2026: Navigating CDSCO Schedule M & Global Compliance
February 18, 2026

Pharmacovigilance India 2026: Navigating CDSCO Schedule M & Global Compliance

The Indian pharmaceutical sector is undergoing a seismic shift. With the November 2025 mandates regarding QR codes for direct adverse event reporting, the volum...

Read Analysis →